|
Volumn 39, Issue 12, 2009, Pages 847-849
|
Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: A placebo-controlled double-blind randomized phase II study (the GONE Study)
|
Author keywords
Colorectal cancer; Goshajinkigan; Japanese herbal medicine; Neurotoxicity; Oxaliplatin
|
Indexed keywords
FLUOROURACIL;
FOLINIC ACID;
GOSHAJINKIGAN;
HERBACEOUS AGENT;
OXALIPLATIN;
PLACEBO;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTINUOUS INFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG WITHDRAWAL;
HUMAN;
INCIDENCE;
MULTIPLE CYCLE TREATMENT;
PERIPHERAL NEUROPATHY;
PHASE 2 CLINICAL TRIAL;
PROGRESSION FREE SURVIVAL;
RANDOMIZED CONTROLLED TRIAL;
ADOLESCENT;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHILD;
COLORECTAL NEOPLASMS;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
DRUG INTERACTIONS;
DRUGS, CHINESE HERBAL;
FEMALE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
MALE;
NEOPLASM STAGING;
NEUROTOXICITY SYNDROMES;
ORGANOPLATINUM COMPOUNDS;
PLACEBOS;
YOUNG ADULT;
|
EID: 70849136155
PISSN: 03682811
EISSN: 14653621
Source Type: Journal
DOI: 10.1093/jjco/hyp100 Document Type: Article |
Times cited : (20)
|
References (8)
|